Literature DB >> 19436809

Translational development of mesenchymal stem cell therapy for cardiovascular diseases.

Joshua M Hare1.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19436809      PMCID： PMC2676608     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  14 in total

1.  Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy.

Authors:  Luciano C Amado; Karl H Schuleri; Anastasios P Saliaris; Andrew J Boyle; Robert Helm; Behzad Oskouei; Marco Centola; Virginia Eneboe; Randell Young; Joao A C Lima; Albert C Lardo; Alan W Heldman; Joshua M Hare
Journal:  J Am Coll Cardiol       Date:  2006-11-01       Impact factor: 24.094

2.  Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction.

Authors:  Luciano C Amado; Anastasios P Saliaris; Karl H Schuleri; Marcus St John; Jin-Sheng Xie; Stephen Cattaneo; Daniel J Durand; Torin Fitton; Jin Qiang Kuang; Garrick Stewart; Stephanie Lehrke; William W Baumgartner; Bradley J Martin; Alan W Heldman; Joshua M Hare
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-01       Impact factor: 11.205

3.  Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons.

Authors:  Kirstin J Beggs; Alex Lyubimov; Jade N Borneman; Amelia Bartholomew; Annemarie Moseley; Robert Dodds; Michael P Archambault; Alan K Smith; Kevin R McIntosh
Journal:  Cell Transplant       Date:  2006       Impact factor: 4.064

4.  Human mesenchymal stem cells modulate allogeneic immune cell responses.

Authors:  Sudeepta Aggarwal; Mark F Pittenger
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

5.  Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness.

Authors:  Shaul Beyth; Zipora Borovsky; Dror Mevorach; Meir Liebergall; Zulma Gazit; Hadi Aslan; Eithan Galun; Jacob Rachmilewitz
Journal:  Blood       Date:  2004-10-28       Impact factor: 22.113

6.  Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Nikos Werner; Jürgen Haase; Jörg Neuzner; Alfried Germing; Bernd Mark; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  Eur Heart J       Date:  2006-11-10       Impact factor: 29.983

7.  The adult Göttingen minipig as a model for chronic heart failure after myocardial infarction: focus on cardiovascular imaging and regenerative therapies.

Authors:  Karl H Schuleri; Andrew J Boyle; Marco Centola; Luciano C Amado; Robert Evers; Jeffrey M Zimmet; Kristine S Evers; Katherine M Ostbye; Diana G Scorpio; Joshua M Hare; Albert C Lardo
Journal:  Comp Med       Date:  2008-12       Impact factor: 0.982

8.  The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.

Authors:  Philippe Menasché; Ottavio Alfieri; Stefan Janssens; William McKenna; Hermann Reichenspurner; Ludovic Trinquart; Jean-Thomas Vilquin; Jean-Pierre Marolleau; Barbara Seymour; Jérôme Larghero; Stephen Lake; Gilles Chatellier; Scott Solomon; Michel Desnos; Albert A Hagège
Journal:  Circulation       Date:  2008-02-19       Impact factor: 29.690

9.  Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.

Authors:  Alain J Poncelet; Jonathan Vercruysse; Alain Saliez; Pierre Gianello
Journal:  Transplantation       Date:  2007-03-27       Impact factor: 4.939

Review 10.  Paracrine mechanisms in adult stem cell signaling and therapy.

Authors:  Massimiliano Gnecchi; Zhiping Zhang; Aiguo Ni; Victor J Dzau
Journal:  Circ Res       Date:  2008-11-21       Impact factor: 17.367
View more
  12 in total

1.  Towards expansion of human hair follicle stem cells in vitro.

Authors:  J H Oh; P Mohebi; D L Farkas; J Tajbakhsh
Journal:  Cell Prolif       Date:  2011-06       Impact factor: 6.831

2.  The stimulation of the cardiac differentiation of mesenchymal stem cells in tissue constructs that mimic myocardium structure and biomechanics.

Authors:  Jianjun Guan; Feng Wang; Zhenqing Li; Joseph Chen; Xiaolei Guo; Jun Liao; Nicanor I Moldovan
Journal:  Biomaterials       Date:  2011-05-12       Impact factor: 12.479

Review 3.  Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease.

Authors:  Adam R Williams; Joshua M Hare
Journal:  Circ Res       Date:  2011-09-30       Impact factor: 17.367

4.  Cell therapy for heart disease: where are we in 2011?

Authors:  Alan W Heldman; Juan P Zambrano; Joshua M Hare
Journal:  J Am Coll Cardiol       Date:  2011-01-25       Impact factor: 24.094

Review 5.  Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges.

Authors:  Pratik A Lalit; Derek J Hei; Amish N Raval; Timothy J Kamp
Journal:  Circ Res       Date:  2014-04-11       Impact factor: 17.367

6.  Mesenchymal stem cells and cardiovascular disease: a bench to bedside roadmap.

Authors:  Manuel Mazo; Miriam Araña; Beatriz Pelacho; Felipe Prosper
Journal:  Stem Cells Int       Date:  2012-01-22       Impact factor: 5.443

7.  Pre-activation of mesenchymal stem cells with TNF-α, IL-1β and nitric oxide enhances its paracrine effects on radiation-induced intestinal injury.

Authors:  Hao Chen; Xiao-Hui Min; Qi-Yi Wang; Felix W Leung; Liu Shi; Yu Zhou; Tao Yu; Chuan-Ming Wang; Geng An; Wei-Hong Sha; Qi-Kui Chen
Journal:  Sci Rep       Date:  2015-03-03       Impact factor: 4.379

8.  Clinical trials of bone marrow derived cells for ischemic heart failure. Time to move on? TIME, SWISS-AMI, CELLWAVE, POSEIDON and C-CURE.

Authors:  Christophe M Raynaud; Magdi H Yacoub
Journal:  Glob Cardiol Sci Pract       Date:  2013-11-01

Review 9.  Cellular Therapeutics for Heart Failure: Focus on Mesenchymal Stem Cells.

Authors:  Amitabh C Pandey; Jordan J Lancaster; David T Harris; Steven Goldman; Elizabeth Juneman
Journal:  Stem Cells Int       Date:  2017-12-17       Impact factor: 5.443

10.  Hypoxic Stress Decreases c-Myc Protein Stability in Cardiac Progenitor Cells Inducing Quiescence and Compromising Their Proliferative and Vasculogenic Potential.

Authors:  Michael A Bellio; Mariana T Pinto; Victoria Florea; Paola A Barrios; Christy N Taylor; Ariel B Brown; Courtney Lamondin; Joshua M Hare; Ivonne H Schulman; Claudia O Rodrigues
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.